10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The diverse nature of bacterial, fungal, and parasitic infections presents unique challenges in diagnosis and treatment. Bacterial infections, ranging from strep throat to sepsis, are commonly treated with antibiotics, but the growing issue of resistance threatens their effectiveness. Fungal infections, such as histoplasmosis and cryptococcosis, often affect immunocompromised individuals and may require long-term antifungal therapy. Meanwhile, parasitic infections, including schistosomiasis and toxoplasmosis, continue to burden millions in endemic areas. These infections not only impact individual health but also strain healthcare systems, emphasizing the need for improved surveillance, rapid diagnostic tools, and innovative therapies to combat their spread and severity.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria